| scholarly article | Q13442814 |
| P2093 | author name string | David Rosen | |
| Raymon Durso | |||
| Anil Modak | |||
| Ephraim Josephs | |||
| P2860 | cites work | The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography | Q48446833 |
| Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa | Q55061662 | ||
| The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport | Q64762121 | ||
| Central levodopa metabolism in Parkinson's disease after administration of stable isotope-labeled levodopa. | Q64961710 | ||
| High-performance liquid chromatographic method for measuring homovanillic acid in cerebrospinal fluid using electrochemical detection with internal standardization | Q68014062 | ||
| Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease | Q69011803 | ||
| Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients | Q69034332 | ||
| Kinetics of homovanillic acid and determination of its production rate in humans | Q70431184 | ||
| Aromatic l-amino acid decarboxylase activity in central and peripheral tissues and serum of rats with l-dopa and l-5-hydroxytryptophan as substrates | Q70899887 | ||
| The effect of carbidopa and entacapone pretreatment on the L-dopa pharmacokinetics and metabolism in blood plasma and skeletal muscle in beagle dog: an in vivo microdialysis study | Q72335318 | ||
| L-dopa dose and the duration and severity of dyskinesia in primed MPTP-treated primates | Q80188582 | ||
| Decreased noradrenaline (norepinephrine) synthesis in familial dysautonomia | Q28364925 | ||
| Limitations of current Parkinson's disease therapy | Q34187123 | ||
| Levodopa and the progression of Parkinson's disease | Q34553278 | ||
| Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate | Q34627496 | ||
| Parkinson's disease: medical treatment of moderate to advanced disease | Q34666449 | ||
| Evaluation of a [13C]-dextromethorphan breath test to assess CYP2D6 phenotype | Q36684887 | ||
| Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease | Q37001159 | ||
| Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial | Q37122442 | ||
| Rapid identification of the hepatic cytochrome P450 2C19 activity using a novel and noninvasive [13C]pantoprazole breath test | Q37162141 | ||
| Recent advances in CSF biomarkers for Parkinson's disease | Q37968076 | ||
| Variable absorption of carbidopa affects both peripheral and central levodopa metabolism | Q40753373 | ||
| The response to levodopa in Parkinson's disease: imposing pharmacological law and order | Q40981288 | ||
| Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics | Q41883836 | ||
| Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa dose | Q42099300 | ||
| Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test | Q44854701 | ||
| Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies | Q45026726 | ||
| Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test. | Q45941262 | ||
| Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians | Q46402944 | ||
| Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group | Q48413069 | ||
| The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism | Q48438376 | ||
| P433 | issue | 4 | |
| P921 | main subject | (S)-(−)-carbidopa monohydrate | Q414225 |
| breathing | Q9530 | ||
| P304 | page(s) | 349-356 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Journal of Parkinson's disease | Q26842319 |
| P1476 | title | A rapid non invasive L-DOPA-¹³C breath test for optimally suppressing extracerebral AADC enzyme activity - toward individualizing carbidopa therapy in Parkinson’s disease | |
| P478 | volume | 2 |
Search more.